Tenet Healthcare Corporation

THC Healthcare Medical Care Facilities

Tenet Healthcare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $21.3 billion, up 3.07% from fiscal 2024.

Revenue
+6.47%
EPS
+291.1%
Free cash flow
+39.2%
Total debt
+0.42%

Quarter to September 2026, against a year earlier

282.69 3.77 −1.32%
Market cap
$22.8B
P/E
7.6×
Fwd P/E
7.5×
Dividend yield
—
F-score
7/9
Altman Z
1.91
Beneish M
−2.67
Dividend safety
57/100

Tenet Healthcare Corporation (THC) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Tenet Healthcare Corporation (THC) trades at a EV/Sales of 1.5×. Over the past ten years it has ranged from 0.8× (December 2016) to 1.6× (August 2026); the current reading is higher than 99% of that period. That is above the Medical Care Facilities industry median of 1.4× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 1.3× 22.22%
FY2024 1.1× 3.56%
FY2023 1.0× 3.04%
FY2022 1.0× (10.15%)
FY2021 1.1× 14.08%
FY2020 1.0× (0.68%)
FY2019 1.0× 12.94%
FY2018 0.9× 6.25%
FY2017 0.8× 1.45%
FY2016 0.8× (11.07%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 1.4× 14.47%
Jun 2026 1.2× (1.33%)
Mar 2026 1.2× (6.24%)
Dec 2025 1.3× (1.67%)
43 more quarters

Against its own ten years

Low 0.8× High 1.6×
Ten-year median 1.0×
Current reading's percentile 99

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on THC